$GNLX
Genelux Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Genelux Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is GNLX down today? It is at $2.20 (-4.82%), and our scanner flagged it 48 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GNLX spikes, and full due diligence on GNLX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $GNLX 48 times in the last 30 days. Create a free account to track $GNLX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how GNLX traded in the last session, Friday (last price and move above). Our scanner fired 12 unusual-volume and momentum alerts on GNLX on Friday, peaking at 16.2x its normal volume.
Likely catalystGENELUX Corp: Q3 FY2026 results, three months to Sep 30, 2026, from the latest SEC filing. Read it →Across every filing on file, supply equal to 118% of the tradeable float is in play - 118% more can still be issued.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
38,610,039 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $100.0M in size · Priced at $2.59/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Yu Yong Officer | Sold (automatic/other) | -668 | sold 0.3% | 258K | $1K at $2.01 | Nov 3, 26 |
Zindrick Thomas Officer | Sold (automatic/other) | -3K | sold 0.3% | 1.22M | $6K at $2.05 | Nov 3, 26 |
Cappello Joseph Officer | Sold (automatic/other) | -668 | sold 0.2% | 318K | $1K at $2.04 | Nov 3, 26 |
Cappello Joseph Officer | Sold (automatic/other) | -10K 0.02% of company | sold 3.1% | 318K | $28K at $2.74 | Aug 31, 26 |
Zindrick Thomas Officer | Sold (automatic/other) | -34K 0.07% of company | sold 2.7% | 1.23M | $92K at $2.67 | Aug 31, 26 |
Yu Yong Officer | Sold (automatic/other) | -10K 0.02% of company | sold 3.6% | 259K | $27K at $2.75 | Aug 31, 26 |
Yu Yong Officer | Sold (automatic/other) | -653 | sold 0.2% | 268K | $2K at $2.94 | Aug 4, 26 |
Zindrick Thomas Officer | Sold (automatic/other) | -3K | sold 0.2% | 1.26M | $9K at $2.95 | Aug 4, 26 |
Cappello Joseph Officer | Sold (automatic/other) | -653 | sold 0.2% | 329K | $2K at $2.95 | Aug 4, 26 |
Smither John W Director | Sold (automatic/other) | -12K 0.02% of company | sold 12% | 91K | $35K at $2.91 | Jul 1, 26 |
Yu Yong Officer | Acquired (grant/award) | +119K 0.2% of company | added 80% | 269K | n/a | Jun 16, 26 |
Smither John W Director | Acquired (grant/award) | +28K 0.06% of company | added 38% | 103K | n/a | Jun 16, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how GNLX traded in the last session, Friday (last price and move above). Our scanner fired 12 unusual-volume and momentum alerts on GNLX on Friday, peaking at 16.2x its normal volume.
GNLX last traded at $2.20, down 4.82% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The GNLX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GNLX 48 times in the last 30 days.
GNLX (Genelux Corporation Common Stock) trades on XNAS, with a market cap of about $104M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GNLX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$GNLX discussion
Sign in to ask a question or join the discussion.